Gene Therapy for CLN3 Batten Disease

Type: gene_therapy

Status: Investigational

Developer: University of Rochester Medical Center, Voyager Therapeutics

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026